BackNature`s Sunshine Products Overview

Nature`s Sunshine Products Other Current Liabilities

Nature`s Sunshine Products's other current liabilities is $51M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$51.11M
48.80% YoYΔ $16.76M vs prior year quarter

Peer average / median

Loading

Nature`s Sunshine Products Other Current Liabilities History

Loading

Nature`s Sunshine Products vs. peers: Other Current Liabilities Comparison

Loading

Nature`s Sunshine Products Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Nature`s Sunshine Products (NATR) FAQ

Nature`s Sunshine Products (NATR) currently reports a other current liabilities of $51M as of June 2026. That compares with $34M in the prior-year period — up 48.8% year over year. Use the charts on this page to explore Nature`s Sunshine Products's other current liabilities history and peer comparisons.

Nature`s Sunshine Products's other current liabilities increased from $34M to $51M — a 48.8% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Nature`s Sunshine Products reported $51M in other current liabilities as of June 2026. That compares with $34M in the prior-year period — up 48.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $51M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Nature`s Sunshine Products, and consider following NATR for alerts when major investors trade the stock.

Nature`s Sunshine Products is classified in the Healthcare sector. On other current liabilities, it currently shows $51M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NATR with unrelated industries.